サマリー

欧州のラジオイムノアッセイ市場は、2023年から2030年の予測期間に4.0%の大幅なCAGRを記録すると予測されています。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。
市場セグメンテーションを行います：
欧州ラジオイムノアッセイ市場：製品タイプ別（ラジオイムノアッセイ試薬・キット、ラジオイムノアッセイアナライザー）、用途別（科学研究、臨床診断）、エンドユーザー別（病院、臨床診断ラボ、学術・研究機関、製薬・バイオ医薬品業界、受託研究機関、その他）、流通チャネル別（直接入札、オンライン販売、第三者流通、その他）、国別（ドイツ、フランス、U．ベルギー、デンマーク、オランダ、スイス、スウェーデン、ポーランド、ノルウェー、フィンランド、その他ヨーロッパ）産業動向と2030年までの予測

欧州ラジオイムノアッセイ市場の成長に寄与する主な要因として、以下のものが挙げられます：
- 高スループットと自動化された手順による、エラーのない正確な結果に対する需要の増加
- 技術的進歩の高まり
- 市場関係者の戦略的な取り組み
- 医学における研究開発の意義が高まる

市場のプレーヤー：

欧州ラジオイムノアッセイ市場の主要な市場関係者は以下の通りです：

- パーキンエルマー株式会社
- エムピーバイオメディカルズ
- テカントレーディングAG
- メルクKGaA
- 株式会社イムノバイオロジーラボラトリーズ
- EUROIMMUN Medizinische Labordiagnostika AG（ユーロイムン メディジニッシェ ラボルダグノスティカ アグ
- ベックマン・コールター社
- デメディテック・ダイアグノスティックス社
- マイバイオソース・ドットコム
- DiaSource（ダイアソース
- ベルソルトテクノロジーズGmbH & Co.KG
- ハイデックスOy.
- アイソトープス研究所
- アブカム・ピーエルシー

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 65
1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF EUROPE RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67
2 MARKET SEGMENTATION 71
2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83
3 EXECUTIVE SUMMARY 84
4 PREMIUM INSIGHTS 87
4.1 PESTEL ANALYSIS 88
4.2 PORTYER’S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90
5 INDUSTRY INSIGHTS: 91
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94
7 MARKET OVERVIEW 95
7.1 DRIVERS 97
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
7.4.1 LACK OF SKILLED PROFESSIONALS 103
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103
8 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104
8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
8.2.1 KITS 109
8.2.2 BUFFER 109
8.2.2.1 SOLUTION 109
8.2.2.2 POWDER 109
8.2.3 STANDARD CONCENTRATES 110
8.2.4 PRECIPITATING REAGENTS 110
8.2.5 RADIOISOTOPES 110
8.2.5.1 BETA EMITTERS 110
8.2.5.1.1 TRITIUM 110
8.2.5.1.2 CARBON-14 111
8.2.5.2 GAMMA EMITTERS 111
8.2.5.2.1 IODINE-125 111
8.2.5.2.2 CHROMIUM-51 111
8.2.5.2.3 COBALT-57 111
8.2.6 ANTIBODY/ANTISERUM 112
8.2.6.1 POLYCLONAL 112
8.2.6.2 MONOCLONAL 112
8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113
9 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION 114
9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
9.3.1 INFECTIOUS DISEASE TESTING 120
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
9.3.2 ALLERGY TESTING 121
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
9.3.3 ONCOLOGY TESTING 121
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.4 ENDOCRINE TESTING 122
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.5 TOXICOLOGY TESTING 123
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
9.3.6 AUTOIMMUNE DISEASE TESTING 123
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
9.3.7 OTHER DISEASE TESTING 124
10 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER 125
10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132
11 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133
11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140
12 EUROPE RADIOIMMUNOASSAY MARKET, BY REGION 141
12.1 EUROPE 142
12.1.1 GERMANY 154
12.1.2 FRANCE 162
12.1.3 U.K. 169
12.1.4 ITALY 176
12.1.5 SPAIN 183
12.1.6 RUSSIA 190
12.1.7 TURKEY 197
12.1.8 NETHERLANDS 204
12.1.9 BELGIUM 211
12.1.10 SWITZERLAND 219
12.1.11 REST OF EUROPE 226
13 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 227
13.1 COMPANY SHARE ANALYSIS: EUROPE 227
14 SWOT ANALYSIS 228
15 COMPANY PROFILE 229
15.1 PERKINELMER INC. 229
15.1.1 COMPANY SNAPSHOT 229
15.1.2 REVENUE ANALYSIS 229
15.1.3 COMPANY SHARE ANALYSIS 230
15.1.4 PRODUCT PORTFOLIO 230
15.1.4 RECENT DEVELOPMENT 231
15.2 MERCK KGAA 232
15.2.1 COMPANY SNAPSHOT 232
15.2.2 REVENUE ANALYSIS 232
15.2.3 COMPANY SHARE ANALYSIS 233
15.2.4 PRODUCT PORTFOLIO 233
15.2.5 RECENT DEVELOPMENTS 233
15.3 BECKMAN COULTER, INC. 235
15.3.1 COMPANY SNAPSHOT 235
15.3.2 COMPANY SHARE ANALYSIS 235
15.3.3 PRODUCT PORTFOLIO 235
15.3.4 RECENT DEVELOPMENT 236
15.4 ABCAM PLC 237
15.4.1 COMPANY SNAPSHOT 237
15.4.2 REVENUE ANALYSIS 237
15.4.3 COMPANY SHARE ANALYSIS 238
15.4.4 PRODUCT PORTFOLIO 238
15.4.5 RECENT DEVELOPMENT 238
15.5 TECAN TRADING AG 239
15.5.1 COMPANY SNAPSHOT 239
15.5.2 REVENUE ANALYSIS 239
15.5.3 COMPANY SHARE ANALYSIS 240
15.5.4 PRODUCT PORTFOLIO 240
15.5.5 RECENT DEVELOPMENT 241
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 242
15.6.1 COMPANY SNAPSHOT 242
15.6.2 PRODUCT PORTFOLIO 242
15.6.3 RECENT DEVELOPMENTS 242
15.7 DEMEDITEC DIAGNOSTICS GMBH 243
15.7.1 COMPANY SNAPSHOT 243
15.7.2 PRODUCT PORTFOLIO 243
15.7.3 RECENT DEVELOPMENTS 244
15.8 DIASOURCE 245
15.8.1 COMPANY SNAPSHOT 245
15.8.2 PRODUCT PORTFOLIO 245
15.8.3 RECENT DEVELOPMENT 245
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 246
15.9.1 COMPANY SNAPSHOT 246
15.9.2 PRODUCT PORTFOLIO 246
15.9.3 RECENT DEVELOPMENTS 246
15.10 HIDEX OY 248
15.10.1 COMPANY SNAPSHOT 248
15.10.2 PRODUCT PORTFOLIO 248
15.10.3 RECENT DEVELOPMENTS 248
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 249
15.11.1 COMPANY SNAPSHOT 249
15.11.2 PRODUCT PORTFOLIO 249
15.11.3 RECENT DEVELOPMENT 251
15.12 INSTITUTE OF ISOTOPES 252
15.12.1 COMPANY SNAPSHOT 252
15.12.2 PRODUCT PORTFOLIO 252
15.12.3 RECENT DEVELOPMENTS 253
15.13 KAMIYA BIOMEDICAL COMPANY 254
15.13.1 COMPANY SNAPSHOT 254
15.13.2 PRODUCT PORTFOLIO 254
15.13.3 RECENT DEVELOPMENTS 254
15.14 MP BIOMEDICALS 255
15.14.1 COMPANY SNAPSHOT 255
15.14.2 PRODUCT PORTFOLIO 255
15.14.3 RECENT DEVELOPMENTS 256
15.15 MYBIOSOURCE.COM. 257
15.15.1 COMPANY SNAPSHOT 257
15.15.2 PRODUCT PORTFOLIO 257
15.15.3 RECENT DEVELOPMENT 257
16 QUESTIONNAIRE 258
17 RELATED REPORTS 261

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 58
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 63
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 64
TABLE 4 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 5 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 6 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 7 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 8 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 9 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 10 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 11 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 77
TABLE 12 EUROPE RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 13 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 82
TABLE 14 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 15 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 83
TABLE 16 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 17 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 18 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 85
TABLE 19 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 20 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
TABLE 22 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 88
TABLE 23 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 88
TABLE 24 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 93
TABLE 25 EUROPE HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 26 EUROPE CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 27 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 29 EUROPE CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 30 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 101
TABLE 32 EUROPE DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 EUROPE ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 34 EUROPE THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 35 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 36 EUROPE RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 111
TABLE 37 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 38 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 39 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 40 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 41 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 42 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 43 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 44 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 45 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 46 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 47 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 48 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 49 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 50 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 51 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 114
TABLE 52 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 114
TABLE 53 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 114
TABLE 54 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 55 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 56 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 57 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 58 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 59 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 61 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 62 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 63 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 64 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 65 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 66 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 67 GERMANY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 69 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 70 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 71 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 72 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 73 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 74 GERMANY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 75 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 76 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 77 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 78 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 79 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 80 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 81 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 122
TABLE 82 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 122
TABLE 83 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 122
TABLE 84 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 123
TABLE 85 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 123
TABLE 86 GERMANY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 87 GERMANY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 88 GERMANY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 89 GERMANY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 90 GERMANY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 91 GERMANY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 92 GERMANY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 93 GERMANY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 125
TABLE 94 GERMANY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 95 GERMANY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 126
TABLE 96 GERMANY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 126
TABLE 97 FRANCE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 98 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 99 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 127
TABLE 100 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 101 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 102 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 103 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 104 FRANCE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 105 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 106 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 107 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 108 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 109 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 110 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 130
TABLE 111 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 130
TABLE 112 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 130
TABLE 113 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 130
TABLE 114 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 130
TABLE 115 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 131
TABLE 116 FRANCE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 117 FRANCE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 118 FRANCE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 119 FRANCE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 120 FRANCE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 121 FRANCE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 122 FRANCE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 123 FRANCE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 133
TABLE 124 FRANCE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 125 FRANCE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 133
TABLE 126 FRANCE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 127 U.K. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 128 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 129 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 134
TABLE 130 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 131 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 132 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 135
TABLE 133 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 134 U.K. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 135 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 136 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 137 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 136